Search Results 581-590 of 16886 for Antagonist
About this study. The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when given alone and in combination ...
... antagonists. Pharmacogenomics. 2019 May; 20 (7):475-481. View PubMed; Staley EM, Simmons SC, Feldman AZ, Williams LA, Pham HP. Monitoring Fondaparinux in the ...
Subjects receiving Gonadotropin-releasing hormone (GnRH) agonists and antagonists are allowed to participate. The patient has not received any other type of ...
Treatment with anti-IL 6, anti-IL-6R antagonists, or with Janus kinase inhibitors (JAKi) in the past 30 days or plans to receive during the study period ...
Patients on 5-LO antagonists (Zileuton). Patients on anti-coagulation. Patients on systemic steroids 6 weeks prior to assessment. Women of childbearing age ...
Drugs that reduce gastric acidity, such as H2-receptor antagonists (eg, ranitidine, famotidine) and proton pump inhibitors (eg, omeprazole, esomeprazole) ...
Endothelin receptor antagonists (eg, ambrisentan, bosentan, macitentan) 2. Phosphoesterase type 5 inhibitors (eg, sildenafil, tadalafil) 3. Guanylate ...
Requires anticoagulation with warfarin or equivalent vitamin K antagonists or treatment with strong CYP3A4/5 inhibitors; Known history of human ...
[MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.